What is Known:
Postnatal corticosteroid is a proposed strategy for preventing Bronchopulmonary Dysplasia (BPD) in preterm neonates. However, it is known that corticosteroids have potential side effects, demanding a careful assessment of their risk-benefit profile before administration.
The predictive tools for BPD developed until the moment have limitations when applied to populations with unique characteristics like preterm born in developing countries, which could affect their accuracy.